The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Nuveen International Eq Idx I TCIHX
- NAV / 1-Day Return 23.69 / +0.13 %
- Total Assets 25.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.190%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 2.89%
- Turnover 5%
USD | NAV as of May 20, 2024 | 1-Day Return as of May 20, 2024, 10:20 PM GMT+0
Morningstar’s Analysis TCIHX
Will TCIHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.43 | 596.2 Mil | Healthcare |
ASML Holding NV | 2.27 | 557.6 Mil | Technology |
Nestle SA | 1.65 | 403.8 Mil | Consumer Defensive |
Toyota Motor Corp | 1.56 | 382.1 Mil | Consumer Cyclical |
Lvmh Moet Hennessy Louis Vuitton SE | 1.44 | 354.1 Mil | Consumer Cyclical |
Shell PLC | 1.25 | 307.2 Mil | Energy |
AstraZeneca PLC | 1.21 | 297.5 Mil | Healthcare |
SAP SE | 1.18 | 289.3 Mil | Technology |
Novartis AG Registered Shares | 1.15 | 282.5 Mil | Healthcare |
Roche Holding AG | 1.04 | 255.2 Mil | Healthcare |